CARA Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into CARA


Also see:
CARA stock yearly return 2014
CARA stock yearly return 2015
CARA stock yearly return 2016
CARA stock yearly return 2017
CARA stock yearly return 2018
CARA stock yearly return 2019
CARA stock yearly return 2020
CARA stock yearly return 2021
CARA stock yearly return 2022
CARA stock yearly return 2023
CARA YTD return
Compare CARA average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 04/28/2014
End date: 04/25/2024
Start price/share: $13.37
End price/share: $0.70
Dividends collected/share: $0.00
Total return: -94.76%
CARA Average Annual Return: -25.54%
Starting investment: $10,000.00
Ending investment: $523.88
Years: 10.00


CARA average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Cara Therapeutics is an early commercial-stage biopharmaceutical company focusing on a new treatment paradigm to improve the lives of patients suffering from pruritus. Co.'s KORSUVA injection is an FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease, in adults undergoing hemodialysis. Co. is developing an Oral KORSUVA (difelikefalin) formulation for the treatment of pruritus in patients with atopic dermatitis, and non-dialysis-dependent chronic kidney disease. Phase 2 trials of Oral KORSUVA (difelikefalin) are ongoing in primary biliary cholangitis, and in notalgia paresthetica patients with moderate-to-severe pruritus. The CARA average annual return 10 years is shown above.

The Average Annual Return on the CARA average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CARA average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CARA average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree CARA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cara Therapeutics (CARA) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CARM Average Annual Return
CASI Average Annual Return
CBUS Average Annual Return
CCCC Average Annual Return
CCEL Average Annual Return
CCRN Average Annual Return
CDMO Average Annual Return
CDNA Average Annual Return
CDRE Average Annual Return
CDTX Average Annual Return
More Healthcare companies »

What has the average annual return been for CARA over the past ten years?
✔️Accepted answer: The ten year CARA average annual return has been -25.54%.

What start date was used in your CARA average annual return calculation?
✔️Accepted answer: The start date was 04/28/2014.

What end date was used in your CARA average annual return calculation?
✔️Accepted answer: The end date was 04/25/2024.

If I had invested $10,000 into CARA ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 04/25/2024, you would have $523.88.

What does that work out to on a total return basis?
✔️Accepted answer: The CARA ten year total return ending 04/25/2024 works out to -94.76%.


Also see:
CARA stock yearly return 2014
CARA stock yearly return 2015
CARA stock yearly return 2016
CARA stock yearly return 2017
CARA stock yearly return 2018
CARA stock yearly return 2019
CARA stock yearly return 2020
CARA stock yearly return 2021
CARA stock yearly return 2022
CARA stock yearly return 2023
CARA YTD return
 

CARA Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.